4.5 Article

Chronic liver disease-relate d mortality in diabetes before and during the COVID-19 in the United States

Related references

Note: Only part of the references are listed.
Article Immunology

Metabolic-Associated Fatty Liver Disease Is Highly Prevalent in the Postacute COVID Syndrome

Jovana Milic et al.

Summary: The prevalence of MAFLD is high in patients with postacute COVID syndrome (PACS), suggesting a specific PACS-cluster phenotype with potential long-term metabolic and cardiovascular health implications.

OPEN FORUM INFECTIOUS DISEASES (2022)

Article Endocrinology & Metabolism

COVID-19 pandemic and weight gain in American adults: A nationwide population-based study

Jagdish Khubchandani et al.

Summary: The study found that during the pandemic, 48% of individuals gained weight, 34% remained the same weight, and 18% lost weight. The largest proportion of weight gain occurred in individuals who were very overweight before the pandemic. Additionally, individuals with anxiety, depression, or symptoms of both tended to have a higher rate of weight gain.

DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2022)

Review Gastroenterology & Hepatology

Women Have a Lower Risk of Nonalcoholic Fatty Liver Disease but a Higher Risk of Progression vs Men: A Systematic Review and Meta-analysis

Maya Balakrishnan et al.

Summary: In a systematic review and meta-analysis, it was found that women have a lower risk of NAFLD than men. However, once NAFLD is established, women have a higher risk of advanced fibrosis than men, especially after age 50 years.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)

Article Public, Environmental & Occupational Health

Provisional Mortality Data - United States, 2020

Farida B. Ahmad et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

Letter Gastroenterology & Hepatology

Mortality Trends in Chronic Liver Disease and Cirrhosis in the United States, Before and During COVID-19 Pandemic

Donghee Kim et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2021)

Article Gastroenterology & Hepatology

Impact of COVID-19 Pandemic on Liver Transplantation and Alcohol-Associated Liver Disease in the USA

George Cholankeril et al.

Summary: Since the start of the COVID-19 pandemic, ALD has become the most common indication for listing and the fastest increasing cause for LT. Collective efforts are urgently needed to stem the rising tide of ALD on health care resources.

HEPATOLOGY (2021)

Letter Gastroenterology & Hepatology

Increasing Mortality Among Patients With Diabetes and Chronic Liver Disease From 2007 to 2017

Donghee Kim et al.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2020)

Article Medicine, General & Internal

Sex and gender: modifiers of health, disease, and medicine

Franck Mauvais-Jarvis et al.

LANCET (2020)

Article Gastroenterology & Hepatology

Changing Trends in Etiology-Based Annual Mortality From Chronic Liver Disease, From 2007 Through 2016

Donghee Kim et al.

GASTROENTEROLOGY (2018)

Review Gastroenterology & Hepatology

Review article: safety and tolerability of direct-acting anti-viral agents in the new era of hepatitis C therapy

D. Banerjee et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2016)

Article Gastroenterology & Hepatology

Mortality From Chronic Liver Diseases in Diabetes

Giacomo Zoppini et al.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2014)

Article Endocrinology & Metabolism

Diabetes and Cause-Specific Mortality in a Prospective Cohort of One Million US Adults

Peter T. Campbell et al.

DIABETES CARE (2012)

Article Oncology

Diabetes and Cancer: A Consensus Report

Edward Giovannucci et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2010)